KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Liabilities and Shareholders Equity (2016 - 2025)

Idexx Laboratories has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $3.4 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $3.4 billion for Q4 2025, up 1.74% from a year ago — trailing twelve months through Dec 2025 was $13.3 billion (down 0.97% YoY), and the annual figure for FY2025 was $3.4 billion, up 1.74%.
  • Liabilities and Shareholders Equity for Q4 2025 was $3.4 billion at Idexx Laboratories, down from $3.4 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for IDXX hit a ceiling of $3.4 billion in Q2 2024 and a floor of $2.3 billion in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $3.0 billion (2023), compared with a mean of $2.9 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 23.39% in 2021 and later dropped 4.17% in 2025.
  • Idexx Laboratories' Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then grew by 12.7% to $2.7 billion in 2022, then grew by 18.68% to $3.3 billion in 2023, then rose by 1.03% to $3.3 billion in 2024, then rose by 1.74% to $3.4 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $3.4 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.3 billion (Q2 2025) per Business Quant data.